人类佩吉病毒感染与淋巴瘤风险及预后:一项北美研究
利用2002至2009年新诊断的2094例淋巴瘤病例和1572例频率匹配对照的风险因素数据与储存血浆样本,检测人类佩吉病毒(HPgV)RNA。HPgV病毒血症与淋巴瘤总体风险呈正相关(OR=2.14),除霍奇金淋巴瘤和慢性淋巴细胞白血病/小淋巴细胞淋巴瘤外各主要亚型亦呈正相关;但HPgV病毒血症与无事件生存(HR=1.00)或总生存(HR=0.97)无关联。
要点
- HPgV病毒血症与淋巴瘤总体风险正相关(OR=2.14,95%CI 1.63-2.80,P<0.0001)。
- 除霍奇金淋巴瘤和慢性淋巴细胞白血病/小淋巴细胞淋巴瘤外,各主要亚型均呈正相关。
- HPgV病毒血症与淋巴瘤总体或各亚型的无事件生存和总生存均无关联。
核心结论
- 这些数据支持HPgV在多种淋巴瘤亚型病因学中可能起作用的假说。
研究设计与样本
- 使用2002至2009年新诊断的2094例淋巴瘤病例和1572例频率匹配对照的风险因素数据与储存血浆样本。
- 血浆样本通过逆转录聚合酶链反应(RT-PCR)检测HPgV RNA,RNA浓度<5000基因组当量/ml者用巢式RT-PCR方法确认。
- 另用新诊断淋巴瘤患者队列研究中的2948例病例(包含病例对照研究的所有病例)评估HPgV在淋巴瘤预后中的作用。
主要发现
- HPgV病毒血症与淋巴瘤总体风险呈正相关(比值比=2.14;95%置信区间1.63-2.80;P<0.0001)。
- 除霍奇金淋巴瘤和慢性淋巴细胞白血病/小淋巴细胞淋巴瘤外,HPgV病毒血症与所有主要亚型风险呈正相关。
- 该关联未受其他淋巴瘤风险因素混杂。
- HPgV病毒血症与淋巴瘤总体的无事件生存(风险比=1.00;95%置信区间0.85-1.18)或总生存(风险比=0.97;95%置信区间0.79-1.20)无关联。
- HPgV病毒血症与任何亚型的无事件生存或总生存均无关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We evaluated the association of Human Pegivirus (HPgV) viraemia with risk of developing lymphoma, overall and by major subtypes. Because this virus has also been associated with better prognosis in the setting of co-infection with human immunodeficiency virus, we further assessed the association of HPgV with prognosis. We used risk factor data and banked plasma samples from 2094 lymphoma cases newly diagnosed between 2002 and 2009 and 1572 frequency-matched controls. Plasma samples were tested for HPgV RNA by reverse transcription polymerase chain reaction (RT-PCR), and those with RNA concentrations <5000 genome equivalents/ml were confirmed using nested RT-PCR methods. To assess the role of HPgV in lymphoma prognosis, we used 2948 cases from a cohort study of newly diagnosed lymphoma patients (included all cases from the case-control study). There was a positive association of HPgV viraemia with risk of lymphoma overall (Odds ratio = 2·14; 95% confidence interval [CI] 1·63-2·80; P < 0·0001), and for all major subtypes except Hodgkin lymphoma and chronic lymphocytic leukaemia/small lymphocytic lymphoma, and this was not confounded by other lymphoma risk factors. In contrast, there was no association of HPgV viraemia with event-free survival (Hazard ratio [HR] = 1·00; 95% CI 0·85-1·18) or overall survival (HR = 0·97; 95% CI 0·79-1·20) for lymphoma overall, or any of the subtypes. These data support the hypothesis for a role of HPgV in the aetiology of multiple lymphoma subtypes.
引用
- Fama A, Xiang J, Link BK, et al. Human Pegivirus infection and lymphoma risk and prognosis: a North American study. Br J Haematol. 2018. PMID: 29808922. doi:10.1111/bjh.15416
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。